Zhengzhou University
Clinical trials sponsored by Zhengzhou University, explained in plain language.
-
New drug combo trial aims to boost lymphoma survival
Disease control Not yet recruitingThis study is testing a combination of three medications—zanubrutinib, rituximab, and lenalidomide—as the first treatment for adults with advanced marginal zone lymphoma, a type of blood cancer. Researchers want to see if this combination helps patients live longer and controls t…
Phase: NA • Sponsor: Zhengzhou University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Multi-Attack trial aims to control aggressive brain cancer
Disease control Not yet recruitingThis study is testing a combination of four treatments for a rare and aggressive type of brain lymphoma. It will enroll 30 adults to see if using a personalized immune cell therapy (CAR-T), a stem cell transplant, and two other drugs together is safe and effective. The goal is to…
Phase: NA • Sponsor: Zhengzhou University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat lymphoma when standard drugs fail
Disease control Not yet recruitingThis study is testing a new combination of four targeted drugs for adults with mantle cell lymphoma, a type of blood cancer, that has come back or stopped responding to a common type of medication called a BTK inhibitor. The goal is to see if this new drug mix can better control …
Phase: PHASE4 • Sponsor: Zhengzhou University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC